'You disappointed us': Why is Canada opposing more transparency in drug prices?

World Health Assembly delegates meeting for WHA72

Frustration at the pharmaceutical industry's high prices and secrecy bubbled over at the World Health Assembly this week as delegates fought for a strongly-worded resolution calling for greater transparency in the cost of clinical trials, drug R&D and prices. But some countries, including Canada, pushed for softer wording that could maintain secrecy in prices and research.



from CBC | Health News http://bit.ly/2K2A7hB

Aucun commentaire:

Enregistrer un commentaire